In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk.
Where this comes from
- Record sourced from PubMed, PMID 36191308.
- Also identified by DOI 10.7326/J22-0072.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Jastreboff AM, Aronne LJ, Ahmad NN, et al. <b>Tirzepatide once weekly for the treatment of obesity.</b> N Engl J Med. 2022;387:205-16. 35658024.
Medical subject headings
- Diabetes Mellitus
- Diabetes Mellitus, Type 2